CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer

Hilbe W., Abacioglu U., Aebersold D. M., Bachouchi M., Brodowicz T., Gaafar R., ...Daha Fazla

Memo - Magazine of European Medical Oncology, cilt.6, sa.2, ss.75-82, 2013 (Hakemli Dergi)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6 Sayı: 2
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1007/s12254-013-0088-6
  • Dergi Adı: Memo - Magazine of European Medical Oncology
  • Sayfa Sayıları: ss.75-82
  • Anahtar Kelimeler: Bone metastases, Lung cancer, Skeletal-related events, Denosumab, RANK ligand, ZOLEDRONIC ACID, DOUBLE-BLIND, PHASE-III, SOLID TUMORS, RISK-FACTORS, RANK LIGAND, SURVIVAL, RADIOTHERAPY, FRACTURES, PLACEBO
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır